Your browser doesn't support javascript.
loading
Framework of the strengths and challenges of clinically integrated trials: An expert panel report.
Peters, Anthony E; Jones, W Schuyler; Anderson, Brian; Bramante, Carolyn T; Broedl, Uli; Hornik, Christoph P; Kehoe, Lindsay; Knowlton, Kirk U; Krofah, Esther; Landray, Martin; Locke, Trevan; Patel, Manesh R; Psotka, Mitchell; Rockhold, Frank W; Roessig, Lothar; Rothman, Russell L; Schofield, Lesley; Stockbridge, Norman; Trontell, Anne; Curtis, Lesley H; Tenaerts, Pamela; Hernandez, Adrian F.
Affiliation
  • Peters AE; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC.
  • Jones WS; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
  • Anderson B; MITRE, Bedford, MA.
  • Bramante CT; Departmentd of Medicine, University of Minnesota Medical School, Minneapolis, MN.
  • Broedl U; Boehringer Ingelheim, Ridgefield, CT.
  • Hornik CP; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Pediatrics, Duke University School of Medicine, Durham, NC.
  • Kehoe L; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
  • Knowlton KU; Intermountain Medical Center Heart Institute, Salt Lake City, UT.
  • Krofah E; Milken Institute, Washington, DC.
  • Landray M; University of Oxford, Oxford, England.
  • Locke T; Margolis Institute for Health Policy, Duke University, Durham, NC.
  • Patel MR; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
  • Psotka M; Inova Heart and Vascular Institute, Falls Church, VA.
  • Rockhold FW; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC.
  • Roessig L; Bayer AG, Wuppertal, Germany.
  • Rothman RL; Vanderbilt University Medical Center, Nashville, TN.
  • Schofield L; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
  • Stockbridge N; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
  • Trontell A; Patient-Centered Outcomes Research Institute (PCORI), Washington, DC.
  • Curtis LH; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC.
  • Tenaerts P; Medable, Palo Alto, CA.
  • Hernandez AF; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC. Electronic address: Adrian.hernandez@duke.edu.
Am Heart J ; 275: 62-73, 2024 Sep.
Article in En | MEDLINE | ID: mdl-38795793
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic Limits: Humans Language: En Journal: Am Heart J Year: 2024 Document type: Article Affiliation country: Nueva Caledonia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic Limits: Humans Language: En Journal: Am Heart J Year: 2024 Document type: Article Affiliation country: Nueva Caledonia Country of publication: Estados Unidos